Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mineralys Therapeutics, Inc.(MLYS) | 8,903,838 | 8,903,838 | 0 | $120.47M | $337.63M | 96.09% | +$217.16M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,167,114 | 1,167,114 | 0 | $11.19M | $13.74M | 3.91% | +$2.54M |